Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

FabG3 2239

Next Previous
X
Search
Drug Profile

FabG3 2239

Alternative Names: Fab-G3-2239

Latest Information Update: 24 Feb 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator FatiAbGen
  • Class Antineoplastics; Immunotherapies; Immunotoxins; Monoclonal antibodies; Recombinant fusion proteins
  • Mechanism of Action Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Research Mesothelioma; Pancreatic cancer

Most Recent Events

  • 22 Feb 2023 Ordaos and FatiAbGen collaborate to develop monoclonal antibodies for treatment of Cancer
  • 26 Aug 2022 FabG3 2239 is available for licensing as of 26 Aug 2022. http://www.fatiabgen.com/sub_fatiabgen.php
  • 26 Aug 2022 Early research in Mesothelioma in South Korea (Parenteral) (FatiAbGen website, August 2022)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top